Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs

In this paper, we first used recombinant influenza viral vector (rIVV) subtype H5N1 expressing from the open reading frame of NS1 80 and NS1 124 amino acids of Brucella outer membrane proteins (Omp) 16 and 19, ribosomal L7/L12, and Cu-Zn superoxide dismutase (SOD) proteins to develop a human brucell...

Descripción completa

Detalles Bibliográficos
Autores principales: Bugybayeva, Dina, Ryskeldinova, Sholpan, Zinina, Nadezhda, Sarmykova, Makhpal, Assanzhanova, Nurika, Kydyrbayev, Zhailaubay, Tabynov, Kaissar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695499/
https://www.ncbi.nlm.nih.gov/pubmed/33274194
http://dx.doi.org/10.1155/2020/1438928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695499/
https://www.ncbi.nlm.nih.gov/pubmed/33274194
http://dx.doi.org/10.1155/2020/1438928

Ejemplares similares